Analyst Amit Bhalla at Citigroup Chas downgraded Cardionet, Inc. BEAT from Hold to Sell rating. Citigroup recently hosted the company’s management at its annual healthcare conference.
Although the company appears to be progressing ahead on schedule on its cost saving initiatives, patient volumes are not meeting expectations. As a result, Citigroup expects volume targets to be revised downward again.
The price target for Cardionet, Inc. has been maintained at $6.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Analyst ColorDowngradesPrice TargetAnalyst RatingsAmit BhallaCitigroupFinancialsHealth CareHealth Care ServicesOther Diversified Financial Services
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in